NCT04402060: A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 |
|
|
| Completed | 1/2 | 72 | US, RoW | APL-9, Vehicle Control | Apellis Pharmaceuticals, Inc. | COVID, Covid-19, Coronavirus, Coronavirus Infection, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome Coronavirus 2, Sars-CoV2, Ards, Acute Respiratory Distress Syndrome | 02/21 | 02/21 | | |